Three options. Only one actually works for your business.
The 2023 reform was a reset. Most of the marketing in the market is still in breach.
The Australian cosmetic surgery industry was reset in July 2023 by the AHPRA-NHMRC reform that followed the Four Corners 'Cosmetic Cowboys' coverage. The advertising rules changed: patient before-and-afters for surgical procedures are out, testimonials are out, influencer endorsements are out, language implying guaranteed outcomes is out, the mandatory 7-day cooling-off period must be disclosed, and the GP-referral-plus-psychological-assessment pathway is now compulsory before any surgery. Cosmetic surgeons (now a distinct AHPRA endorsement, separate from the RANZCS Plastic surgeons) are operating in a market where most competitor websites are still in breach, most agencies are still selling old-rule strategies, and a single Instagram post by an enthusiastic patient can put your registration in front of the Cosmetic Surgery Committee. Meanwhile a rhinoplasty consultation still costs $1500 to deliver and the patient takes weeks to decide. The marketing has to do real work, compliantly, or you lose to the practice that ignores the rules and gets fined later.
Good cosmetic surgery marketing in the post-2023 environment is three things, in this order: a procedure-page library that explains each surgical procedure (rhinoplasty, breast augmentation, facelift, abdominoplasty, liposuction) in evidence-based language with realistic recovery timelines, indicative pricing bands, the mandatory cooling-off and GP-referral pathway, and the full informed-consent process: a website that qualifies the patient before they ever book the $1500 consult so your surgical time isn't burned on people who were never going to go through with it: and a non-surgical division (injectables, laser, energy-based devices) with its own positioning that doesn't get tangled in the surgical-only AHPRA rules. The practices that grow in this market are the ones that take the reform seriously, build the patient-education infrastructure for an informed-consent decision, and stop competing for the price-shopper who's going to a backstreet operator anyway.
Six agents, working in your accounts.
Account Lead, Web, SEO, Advertising, Social Media, and Content. One platform, one bill, you approve the work.
Sets the plan around the post-2023 reality: separate surgical and non-surgical positioning, consult-funded acquisition that qualifies the patient before they book, and a content cadence that builds trust without breaching the AHPRA cosmetic surgery advertising rules. Briefs the other agents so the procedure pages, the ads, the educational content and the consult-booking flow all push toward an informed-consent decision, not a Snapchat-pressure purchase.
Imports your existing site, audits every page against the post-July-2023 AHPRA cosmetic surgery advertising rules (removes before-and-afters, testimonials, influencer content, comparative claims), ships compliant procedure pages with the mandatory GP-referral pathway and 7-day cooling-off surfaced, and keeps the surgical-versus-non-surgical division clearly separated.
Owns whether you appear for procedure-specific searches ('rhinoplasty [suburb]', 'breast augmentation [city]', 'cosmetic surgeon [suburb]'). MedicalProcedure schema with the AHPRA-compliant cooling-off and informed-consent disclosures, internal links from the consult-booking flow back to the procedure pages, and the technical fixes that keep you indexed. Auto-applies the low-risk fixes, flags anything that touches AHPRA territory.
Runs Google Ads on procedure-specific queries with compliant copy (no 'best', no 'guaranteed', no scarcity, no testimonials). Pauses immediately on any flagged term. A small Meta layer for the non-surgical division only (laser, injectables, RF microneedling) where the rules are less restrictive. The surgical-procedure Meta ad set requires explicit Account Lead approval, line by line.
Posts evidence-based patient-education in your real accounts: an explainer on what the 7-day cooling-off actually achieves, an evidence-based explainer on rhinoplasty recovery, a post on why the practice no longer uses before-and-afters, a clinical-team spotlight. No patient images for surgical procedures (banned), no testimonials, no influencer reposts, no comparative claims. The non-surgical content (laser, injectables) runs under different rules and the agent knows the difference.
Drafts the long-form patient-education content that pulls the informed-consent reader: 'what to expect in a cosmetic surgery consultation in 2026', 'what the AHPRA cosmetic surgery reform actually changed', 'rhinoplasty recovery week by week', 'how to choose a cosmetic surgeon (the questions to ask)'. Two drafts a fortnight, evidence-based, in your voice.
Your first 30 days.
- Existing site imported, hosting torn down; existing consult-booking CRM stays untouched
- Site-wide post-July-2023 AHPRA cosmetic surgery advertising audit: every breach flagged and remediated in the first week
- Surgical procedure pages (rhinoplasty, breast augmentation, facelift, abdominoplasty, liposuction) restructured with the mandatory GP-referral pathway, psychological assessment, 7-day cooling-off and full informed-consent process surfaced
- Non-surgical division (laser, injectables, RF microneedling, body contouring) split into its own page library with separate positioning
- Consultation-funded acquisition wired to qualify the patient before the $1500 informed-consent consult
- AHPRA-compliant evidence-based content cadence queued in the cosmetic surgeon's voice for the next fortnight
- Mater / St Vincent's / Macquarie Health hospital theatre affiliation surfaced on the about-the-practice page
- CPA / ACCS membership and AHPRA cosmetic surgery endorsement credentials surfaced on every surgeon's bio page
The 2023 reform changed the rules and most of the cosmetic surgery marketing in the Australian market is still in breach. Patient before-and-afters for surgical procedures, testimonials, influencer endorsements, 'best in Sydney', 'guaranteed results': all banned, all still everywhere. The practices that grow in this market are the ones that take the reform seriously, rebuild the procedure pages around evidence-based informed-consent infrastructure, and stop trying to compete with the backstreet operators who'll be fined later. The marketing job is harder, the patient is more informed, and the practice that does it properly wins the high-value surgical work.
Agencies are too dear and too old-school for the post-2023 rules at $5k a month. Tools are cheap but compliant copy under the new cosmetic surgery rules is a part-time job. In-House is the third option: for $299 a month the agents audit your site against the post-July-2023 AHPRA rules, ship compliant procedure pages, run the consultation-funded acquisition, and keep the surgical-versus-non-surgical positioning sharp. Compliant by construction, two taps to approve, minutes a day.